Pine River Capital Management L.P. - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 112 filers reported holding WUXI PHARMATECH CAYMAN INC in Q2 2013. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
Pine River Capital Management L.P. ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$88,114,000
+1618.0%
2,039,192
+1580.2%
1.13%
+1916.1%
Q2 2015$5,129,000
+419.7%
121,364
+314.2%
0.06%
+330.8%
Q4 2014$987,000
-12.0%
29,300
-8.4%
0.01%0.0%
Q3 2014$1,121,000
+6.6%
32,0000.0%0.01%
-18.8%
Q2 2014$1,052,000
+34.7%
32,000
+50.9%
0.02%
+33.3%
Q1 2014$781,000
+114.0%
21,200
+123.2%
0.01%
+200.0%
Q4 2013$365,000
+62.2%
9,500
+15.9%
0.00%
+100.0%
Q3 2013$225,000
+6.1%
8,200
-18.8%
0.00%
-33.3%
Q2 2013$212,00010,1000.00%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q2 2013
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 448,361$15,096,00021.12%
Sloane Robinson LLP 107,400$3,616,0006.28%
Sensato Investors LLC 327,754$11,035,0003.26%
Grandeur Peak Global Advisors, LLC 388,810$13,091,0002.94%
GRATRY & Co LLC 205,800$7,899,0002.59%
THOMAS WHITE INTERNATIONAL LTD 464,926$15,654,0002.15%
COMGEST GLOBAL INVESTORS S.A.S. 1,819,980$61,279,0001.87%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,169,686$39,383,0001.64%
Ninety One North America, Inc. 133,372$4,491,0001.32%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 87,560$2,948,0001.27%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders